AI TextQuick Glance (AI)Headnote
Issues: (i) Whether the transfer-pricing adjustment for electricity transferred by the captive power plant to eligible units was sustainable; (ii) Whether disallowance under section 14A read with Rule 8D could exceed exempt dividend income and be added to book profit; (iii) Whether the Pfizer patent-settlement payment was deductible as business expenditure; (iv) Whether interest incurred on financing the Pfizer settlement was deductible; (v) Whether software expenditure was allowable as revenue expenditure; (vi) Whether disallowance of business-promotion gift expenditure was sustainable; (vii) Whether deduction for foreign taxes was to be granted; (viii) Whether relief granted on the Revenue's transfer-pricing adjustments concerning loans to associated enterprises and sales to associated enterprises was sustainable; (ix) Whether relief concerning weighted research-and-development deductions and allocation of research-and-development expenditure was sustainable; (x) Whether deletion of additions concerning wealth-tax provision under section 115JB and the Cephalon patent settlement was sustainable.
Issue (i): Whether the transfer-pricing adjustment for electricity transferred by the captive power plant to eligible units was sustainable.
Analysis: The issue was covered by the Tribunal's order in the assessee's own case for the preceding assessment year, with no change in facts or law.
Conclusion: The adjustment was deleted, in favour of the assessee.
Issue (ii): Whether disallowance under section 14A read with Rule 8D could exceed exempt dividend income and be added to book profit.
Analysis: The exempt dividend earned was lower than the disallowance computed. The disallowance was therefore confined to the exempt dividend amount. The section 14A disallowance was not liable to be imported into computation of book profit under section 115JB.
Conclusion: The disallowance was restricted to exempt dividend income and no corresponding addition to book profit was permissible, in favour of the assessee.
Issue (iii): Whether the Pfizer patent-settlement payment was deductible as business expenditure.
Analysis: The settlement was a genuine, negotiated resolution of private patent litigation without any final adjudication or admission of guilt. It was incurred to avoid continuing litigation and protect business interests. The payment was compensatory and revenue in character, not a penalty or expenditure for a purpose prohibited by law. For the relevant assessment year, Explanation 1 to section 37(1) did not extend to alleged violations of foreign law, and the later expansion of its scope could not operate retrospectively. The liability crystallised after the appointed date under a court-sanctioned demerger scheme and vested in the assessee.
Conclusion: The Pfizer settlement payment was allowable under section 37(1), in favour of the assessee.
Issue (iv): Whether interest incurred on financing the Pfizer settlement was deductible.
Analysis: The interest claim was consequential to the allowability of the underlying Pfizer settlement expenditure.
Conclusion: The interest deduction was allowable, in favour of the assessee.
Issue (v): Whether software expenditure was allowable as revenue expenditure.
Analysis: Depreciation on the software expenditure had already been claimed and allowed.
Conclusion: No interference with the treatment of the expenditure as capital was warranted, against the assessee.
Issue (vi): Whether disallowance of business-promotion gift expenditure was sustainable.
Analysis: The expenditure was connected with business activities and its genuineness was not disproved. A fifty per cent ad hoc disallowance solely for want of complete recipient particulars lacked cogent evidentiary basis.
Conclusion: The disallowance was directed to be deleted after verification of expenditure details, in favour of the assessee.
Issue (vii): Whether deduction for foreign taxes was to be granted.
Analysis: Verification of the foreign-tax claim was required.
Conclusion: The issue was remanded for verification and grant of eligible deduction.
Issue (viii): Whether relief granted on the Revenue's transfer-pricing adjustments concerning loans to associated enterprises and sales to associated enterprises was sustainable.
Analysis: The relief was consistent with binding coordinate-bench orders in the assessee's own earlier assessment years, without any changed factual or legal position.
Conclusion: The relief was sustained, in favour of the assessee.
Issue (ix): Whether relief concerning weighted research-and-development deductions and allocation of research-and-development expenditure was sustainable.
Analysis: The issues concerning specified research-and-development expenses, weighted deduction and allocation were covered by orders in the assessee's own earlier years, including a position affirmed by the High Court for one year.
Conclusion: The relief was sustained, in favour of the assessee.
Issue (x): Whether deletion of additions concerning wealth-tax provision under section 115JB and the Cephalon patent settlement was sustainable.
Analysis: Both matters were governed by coordinate-bench decisions in the assessee's own earlier cases, with no material change in facts or law.
Conclusion: The deletions were sustained, in favour of the assessee.
Final Conclusion: The assessee obtained relief on the captive-power transfer-pricing adjustment, the Pfizer settlement and related interest, section 14A and book-profit computation, and business-promotion expenditure, while software treatment was retained and the foreign-tax claim required verification; the Revenue's challenges to the relief granted by the first appellate authority did not succeed.
Ratio Decidendi: A genuine compensatory payment under an out-of-court settlement of foreign patent litigation, made without proven guilt to protect business interests, is deductible as revenue expenditure where the applicable version of section 37(1) does not cover alleged contraventions of foreign law.
Patent-settlement deductibility permits compensatory foreign litigation payments, while exempt-income limits govern disallowance and book-profit adjustments.
Deductibility of a genuine compensatory patent-settlement payment is examined under section 37(1), with the payment characterised as revenue expenditure where it resolves foreign patent litigation, protects business interests, and involves no proven guilt or prohibited purpose under the applicable law. Related financing interest is treated as consequential to the settlement's allowability. The material also addresses transfer-pricing treatment of captive-power transfers and associated-enterprise transactions; the cap on section 14A disallowance at exempt income and exclusion from book-profit computation; business-promotion expenditure; foreign-tax credit verification; research-and-development deductions; and wealth-tax provisions in book-profit computation. Software expenditure remains capital where depreciation has been claimed and allowed.
Transfer pricing adjustment on transfer of electricity by Captive Power Plant ("CPP") - Allowability of compensatory patent-settlement expenditure - Explanation 1 to section 37(1) and foreign-law contraventions - Prospective operation of Explanation 3 to section 37(1) - Disallowance of expenditure relating to exempt income - Book-profit adjustment for exempt-income expenditure Transfer pricing of captive-power transfers - Arm's length pricing of electricity transferred by the captive power plant to the assessee's manufacturing units - HELD THAT: - In the absence of any change in the factual matrix or legal proposition, the issue was held covered by the Tribunal's order in the assessee's own case for AY 2013-14 [2022 (8) TMI 1443 - ITAT AHMEDABAD] thus the addition made by the Assessing Officer is ordered to be deleted [Paras 6] The transfer-pricing adjustment was deleted. Disallowance of expenditure relating to exempt income u/s 14A - Book-profit adjustment for exempt-income expenditure - HELD THAT: - The disallowance was restricted to the amount of exempt dividend earned. The Tribunal further held that the provisions for computing book profit under section 115JB were not attracted to this disallowance. [Paras 7] The assessee's ground was partly allowed and the Revenue's corresponding grounds were dismissed. Allowability of compensatory patent-settlement expenditure - Explanation 1 to section 37(1) and foreign-law contraventions - Prospective operation of Explanation 3 to section 37(1) - Revenue character of litigation-settlement expenditure - Deductibility of expenditure incurred under an out-of-court settlement of United States patent-infringement litigation assumed under a court-sanctioned demerger scheme - HELD THAT: - A settlement of civil patent litigation, made without admission or adjudication of guilt, could not be treated as proof of an offence or as expenditure for a purpose prohibited by law. The payment was compensatory, incurred out of commercial expediency to resolve litigation and protect the existing business, and did not acquire a capital asset or enduring advantage in the capital field. For the relevant year, Explanation 1 to section 37(1) did not extend to an alleged infraction of foreign law; Explanation 3, which widened that scope, operated prospectively. The liability had crystallised after the appointed date and stood vested in the assessee by the court-sanctioned demerger scheme; in the absence of material showing that the scheme was a sham, it could not be characterised as a colourable device. It is not in dispute that the profits arising from the sale of goods by the assessee to SPG FZE had been offered to tax by the assessee in the earlier years, and that the transactions between the assessee and the UAE entity were at all times subject to tax in India. Revenue, having brought to tax the profits arising out of the very same business arrangement with the UAE entity, cannot be permitted to turn around and disown the corresponding liability arising out of that very business when it crystallised. Revenue cannot approbate and reprobate; having accepted and taxed the gains of the arrangement, it must also accept the liabilities associated with such arrangement. We find that the out-of-court settlement expenditure was incurred genuinely out of commercial expediency, pertains directly to the assessee's business, is revenue in character, and is completely outside the restrictive bars of Explanation 1 to Section 37(1).[Paras 8] The settlement expenditure was allowed as a revenue business deduction under section 37(1). Interest on financing of allowable settlement liability - Deductibility of interest incurred on financing obtained for the patent-settlement liability - HELD THAT: - The interest claim was consequential to the allowance of the underlying settlement expenditure. [Paras 10] The interest deduction was allowed; the related book-profit ground was infructuous. Characterization of computer-software expenditure - Claim for revenue deduction of computer-software expenditure - HELD THAT: - As depreciation on the entire software expenditure had already been claimed and allowed, no interference with the finding treating it as capital expenditure was warranted. [Paras 11] The assessee's claim was rejected. Ad hoc disallowance of business-promotion expenditure incurred on gifts - HELD THAT: - Where expenditure was connected with business activities and its genuineness was not disproved, an ad hoc disallowance merely because complete particulars of recipients were not furnished could not be sustained without cogent material. [Paras 12] The disallowance was directed to be deleted after due verification of expenditure details, and the ground was allowed for statistical purposes. Deduction of foreign taxes not eligible for tax credit - Claim for deduction of foreign taxes for which no tax credit was available - HELD THAT: - The claim required verification. [Paras 13] The matter was remanded to the Assessing Officer for verification and allowance in accordance with law. Transfer-pricing adjustment on associated-enterprise loans - Transfer-pricing adjustment on sales to associated enterprises - Revenue's challenge to deletion of transfer-pricing adjustments concerning interest on loans to associated enterprises and pricing of sales to associated enterprises - HELD THAT: - The issues were covered by earlier Tribunal orders in the assessee's own case [2017 (6) TMI 1323 - ITAT AHMEDABAD] and [2017 (9) TMI 1804 - ITAT AHMEDABAD], and no change in facts or law was shown. [Paras 15, 16] The relief granted by the Commissioner (Appeals) was affirmed. Weighted deduction for in-house research and development expenditure - Allocation of research and development expenditure - HELD THAT: - The issues were held covered by earlier Tribunal orders in the assessee's own case [2017 (9) TMI 1804 - ITAT AHMEDABAD] and [2016 (12) TMI 1539 - ITAT AHMEDABAD], with no change in the factual matrix or legal proposition. [Paras 17, 18, 21] The relief granted by the Commissioner (Appeals) was affirmed. Wealth-tax provision in book-profit computation - Addition of provision for wealth tax in computing book profit under section 115JB. - HELD THAT: - The issue was covered by an earlier Tribunal order in the assessee's own case [2017 (9) TMI 1804 - ITAT AHMEDABAD], and no change in facts or law was shown. [Paras 19] The relief granted by the Commissioner (Appeals) was affirmed. Allowability of patent-settlement expenditure - payment under an out-of-court settlement of a patent-infringement suit - HELD THAT: - The issue was covered by the Tribunal's order in the assessee's own case for AY 2012-13 [2021 (9) TMI 1164 - ITAT AHMEDABAD], with no change in the factual matrix or legal proposition. [Paras 22] The relief granted by the Commissioner (Appeals) was affirmed. Final Conclusion: The assessee's appeal was partly allowed, with the principal patent-settlement expenditure and consequential interest allowed, while specified matters were remanded for verification. The Revenue's appeal was dismissed.